Evidence map›Paper›PMID 31824494›Full record

ArticleFrontiers in immunology2019

Diurnal Variation in Systemic Acute Inflammation and Clinical Outcomes Following Severe Blunt Trauma.

Akram M Zaaqoq, Rami A Namas, Othman Abdul-Malak, Khalid Almahmoud, Derek Barclay, Jinling Yin, Ruben Zamora, Matthew R Rosengart, Timothy R Billiar, Yoram Vodovotz

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Circadian Disruption in Critical Illness.Frontiers in neurology · 2020
    Review
  11. Prognostic Value of Antithrombin Activity Levels in the Early Phase of Intensive Care: A 2-Center Retrospective Cohort Study.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Akram M ZaaqoqDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Rami A NamasDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Othman Abdul-MalakDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Khalid AlmahmoudDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Derek BarclayDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Jinling YinDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Ruben ZamoraDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Matthew R RosengartDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Timothy R BilliarDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
Yoram VodovotzDepartment of Surgery, University of Pittsburgh, Pittsburgh, PA, United States.
University of Pittsburgh · USMcGowan Institute for Regenerative Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Animal studies suggest that the time of day is a determinant of the immunological response to both injury and infection. We hypothesized that due to this diurnal variation, time of injury could affect the systemic inflammatory response and outcomes post-trauma and tested this hypothesis by examining the dynamics of circulating inflammatory mediators in blunt trauma patients injured during daytime vs. nighttime. From a cohort of 472 blunt trauma survivors, two stringently matched sub-cohorts of moderately/severely injured patients [injury severity score (ISS) >20] were identified. Fifteen propensity-matched, daytime-inured ("mDay") patients (age 43.6 ± 5.2, M/F 11/4, ISS 22.9 ± 0.7) presented during the shortest local annual period (8:00 am-5:00 pm), and 15 propensity-matched "mNight" patients (age 43 ± 4.3, M/F 11/4, ISS 24.5 ± 2.5) presented during the shortest night period (10:00 pm-5:00 am). Serial blood samples were obtained (3 samples within the first 24 h and daily from days 1-7) from all patients. Thirty-two plasma inflammatory mediators were assayed. Two-way Analysis of Variance (ANOVA) was used to compare groups. Dynamic Network Analysis (DyNA) and Dynamic Bayesian Network (DyBN) inference were utilized to infer dynamic interrelationships among inflammatory mediators. Both total hospital and intensive care unit length of stay were significantly prolonged in the mNight group. Circulating IL-17A was elevated significantly in the mNight group from 24 h to 7 days post-injury. Circulating MIP-1α, IL-7, IL-15, GM-CSF, and sST2 were elevated in the mDay group. DyNA demonstrated elevated network complexity in the mNight vs. the mDay group. DyBN suggested that cortisol and sST2 were central nodes upstream of TGF-β1, chemokines, and Th17/protective mediators in both groups, with IL-6 being an additional downstream node in the mNight group only. Our results suggest that time of injury affects clinical outcomes in severely injured patients in a manner associated with an altered systemic inflammation program, possibly implying a role for diurnal or circadian variation in the response to traumatic injury.

Indexed as

AdultBayes TheoremChemokinesCircadian RhythmFemaleHumansInflammationMaleMiddle AgedRetrospective StudiesWounds, NonpenetratingChemokinesacute inflammationblunt traumachemokinescircadian rhythmnervous system

Identifiers

PMID31824494
PMCPMC6879654
OpenAlexW2990962683

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.